Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinibINTERNATIONAL JOURNAL OF CANCERIF4.72019-06-2550OAAI
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemiaLEUKEMIAIF13.42010-09-0227PREAI
BCR-ABL kinase domain mutations and clonal evolution as major causes of resistance to targeted therapy in chronic myelogenous leukemiaBLOOD REVIEWSIF5.72007-08-010PREAI
First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts表达罕见e1a2或e19a2 bcr-abl转录本的慢性粒细胞白血病患者的一线和二线伊马替尼治疗HEMATOLOGICAL ONCOLOGYIF3.92007-05-2523PREAI
Reduction of Bcr-Abl function leads to erythroid differentiation of K562 cells via downregulation of ERKSIGNAL TRANSDUCTION PATHWAYS, PT A: APOPTOTIC AND EXTRACELLULAR SIGNALINGIF02007-01-2613PREAI
Hepatosplenic γδ T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberrationVIRCHOWS ARCHIVIF3.12006-08-2920PRE
In vitro expansion of long-term repopulating hernatopoietic stem cells in the presence of immobilized Jagged-1 and early acting cytokinesCELL BIOLOGY INTERNATIONALIF3.12006-05-0120PREAI